Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Vandana Singh

Endo Acquires Six Development-Stage, Injectable Product Candidates For $35M

  • Endo International plc (NASDAQ:ENDP) has acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc, a subsidiary of Nevakar Inc.
  • Under the agreement terms, Endo purchased the six product candidates from Nevakar Injectables for a one-time payment of $35 million to be expensed immediately in Q2 as acquired in-process research and development costs. 
  • This acquisition is separate from Endo's previously announced exclusive licensing agreement with Nevakar.
  • "These six product candidates that would be used in critical care settings meaningfully expand Endo's ready-to-use injectable product pipeline," said Scott Sims, Senior Vice President and General Manager, Injectable Solutions & Generics at Endo.
  • The product candidates are in various stages of development, with the first launch expected in 2025.
  • Price Action: ENDP shares are up 5.50% at $2.11 during the market session on the last check Monday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.